Bayer Ag

  • Natco Pharma shares surge 5.3 pc after patent ruling March 5, 2013

    Mumbai: Shares in Natco Pharma Ltd surge 5.3 per cent after an Indian patent appeals board upheld on Monday a decision to allow the company to sell a generic version of Bayer AG's cancer drug Nexavar. "It would have positive earnings implication for Natco and opens up new avenues of compulsory...